SCHEMBL1310048

SCHEMBL1310048

O=C1OCCC1=CNCc1ccccc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.50
HSP90AB1 P08238 1/20 0.50
ALDH1A1 P00352 2/20 0.44
GAA P10253 2/20 0.44
MAPT P10636 1/20 0.44
NAMPT P43490 1/20 0.41
MAPK1 P28482 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
PKM P14618 1/20 0.39
KMT2A Q03164 3/20 0.38
CYP2A13 Q16696 1/20 0.38
MEN1 O00255 1/20 0.38
TP53 P04637 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
RECQL P46063 1/20 0.38
PIK3CA P42336 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1310500 0.79 KMT2A (0.60) HSP90AA1HSP90AB1ALDH1A1GAAMAPT
SCHEMBL1310955 0.78 KMT2A (0.49) HSP90AA1HSP90AB1ALDH1A1GAAMAPT
SCHEMBL1325020 0.74 HSP90AA1 (0.49) HSP90AA1HSP90AB1ALDH1A1GAAMAPT
SCHEMBL14972752 0.73 HSP90AA1 (0.49) HSP90AA1HSP90AB1ALDH1A1GAAMAPT
SCHEMBL1310328 0.72 KMT2A (0.55) HSP90AA1HSP90AB1ALDH1A1GAAMAPT
SCHEMBL1311593 0.71 HSP90AA1 (0.56) HSP90AA1HSP90AB1ALDH1A1GAAMAPT
SCHEMBL14972764 0.71 KMT2A (0.66) HSP90AA1HSP90AB1ALDH1A1GAAMAPT
SCHEMBL14972763 0.71 KMT2A (0.66) HSP90AA1HSP90AB1ALDH1A1GAAMAPT
SCHEMBL1308721 0.70 HSP90AA1 (0.50) HSP90AA1HSP90AB1ALDH1A1GAAMAPT
SCHEMBL1310049 0.70 ALDH1A1 (0.45) ALDH1A1GAAMAPTMAPK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846125-B2 Enaminocarbonyl compounds and their use INSTYTUT CHEMII ORGANICZNEJ, POLSKA AKADEMIA NAUK (PL) 2014-09-30 US disclosed
EP-2391614-B1 ENAMINOCARBONYL COMPOUNDS AND THEIR USE INST CHEMII ORGANICZNEJ POLSKA AKADEMIA NAUK (PL) 2013-05-29 EP disclosed
EP-2391614-A1 ENAMINOCARBONYL COMPOUNDS AND THEIR USE Instytut Chemii Organicznej, Polska Akademia Nauk (PL) 2011-12-07 EP disclosed
US-20110274803-A1 ENAMINOCARBONYL COMPOUNDS AND THEIR USE INSTYTUT CHEMII ORGANICZNEJ, POLSKA AKADEMIA NAUK (PL) 2011-11-10 US disclosed
WO-2010087727-A1 ENAMINOCARBONYL COMPOUNDS AND THEIR USE INSTYTUT CHEMII ORGANICZNEJ, POLSKA AKADEMIA NAUK (PL) 2010-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110274803-A1 ENAMINOCARBONYL COMPOUNDS AND THEIR USE TAS2R42, TAS2R41, TAS2R1 HSP90AA1 4418/4885HSP90AB1 4303/4885ALDH1A1 1125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.